Medreich facilities have received the seal of approval from leading global regulatory bodies such as -UK MHRA, Australia TGA, SA MCC, Health Canada, and French AFSSAP, GCC, PIC, regulatory bodies of various countries in the African continent and independent bodies like UNICEF and MSF.
A blend of manufacturing, research and development, documentation services, deep insights in the pharmaceutical domain, enduring partnership, and above all the passion to win, translates into the Medreich advantage in the areas of Quality, Innovation, Value addition and Every Time - On Time deliveries.
The specialized and premier positioning is the result of years of planned investment in manufacturing facilities, client servicing, people and technology.
Medreich has six manufacturing facilities in India and one in Spain built to comply with standards stipulated by international regulatory bodies and multinational pharmaceutical companies.
Medreich was one of the early companies to have a dedicated betalactam manufacturing facility in early 90's. In addition to this betalactam facility Medreich now has two dedicated Cephalosporin manufacturing facilities.
HISTORY
In 1994, when Smithkline Beecham tasked Medreich plc to source quality generic drugs, for its Africa operations, it came upon a little company that had world class quality parameters. This company was guided by the Beecham technical and regulatory protocols that it used in its own facility in UK. The little company, Medreich, has come a long way since then. But the guiding principles remain the same - aim to make a difference through leveraging technological excellence by way of building partnerships with strong and vibrant local partners,
around the globe.
GLOBAL REACH - Local Partnerships
The combination of worldwide scale and local insight gives the organisation solid foundations on which to grow. Good internal and external communication between the partners and the centre will help ensure long-term prosperity. The organisation nurtures the key values of customer, performance, innovation and sense of urgency in the way we work.
